External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Angiogenesis 2026

We will be contributing to topics related to
-
08:55 PM
Duration 8mins Virtual
Machine Learning-Based Volumetric Analysis of nAMD Biomarkers in TENAYA/LUCERNE
Mark Barakat
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:05 PM
Duration 8mins Virtual
Global Real-World Data With Faricimab▼ in nAMD and DME: The VOYAGER Study
Veeral Sheth
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:15 PM
Duration 8mins Virtual
Four-Year Outcomes of Faricimab▼ in nAMD: Safety and Efficacy Results From the AVONELLE-X Long-Term Extension Trial
Carl Danzig
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:25 PM
Duration 8mins Virtual
Faricimab▼ for Polypoidal Choroidal Vasculopathy: 1-Year Results from the Phase 3b/4 SALWEEN Trial
Gemmy Cheung
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:40 PM
Duration 8mins Virtual
Pagoda Trial Results Through Year 4: Port Delivery Platform with Ranibizumab for the Treatment of DME
Dante Pieramici
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:55 PM
Duration 8mins Virtual
DME OCT Retinal Fluid (IRF Cyst Turbidity)
Jennifer Lim
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon